FDA Approved: IMPAVIDO — Original Application (Profounda, Inc.)

View source ↗

Summary

FDA approved IMPAVIDO (miltefosine) through Profounda, Inc. via Original Application (NDA204684) for visceral leishmaniasis and post-kala-azar dermal leishmania…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-kala-azar Dermal Leishmaniasis
• Visceral Leishmaniasis

Drugs mentioned

• Impavido (miltefosine)

Snippet

ORIG AP for IMPAVIDO (MILTEFOSINE)